🧪
hypothesis

IRP2-Iron Axis Modulation to Reduce Ferroptotic Vulnerability

Hypothesis

IRP2-Iron Axis Modulation to Reduce Ferroptotic Vulnerability

NOT RECOMMENDED.
🧬 IRP2-Iron🩺 neurodegeneration🎯 Composite 40%💱 $0.48▲19.9%proposed
EvidencePending (0%)📖 0 cit🗣 1 debates 4 support 4 oppose
✓ All Quality Gates Passed
Mechanistic 0.35 (15%) Evidence 0.48 (15%) Novelty 0.62 (12%) Feasibility 0.25 (12%) Impact 0.40 (12%) Druggability 0.28 (10%) Safety 0.42 (8%) Competition 0.28 (6%) Data Avail. 0.48 (5%) Reproducible 0.42 (5%) KG Connect 0.50 (8%) 0.398 composite
☰ Compare⚔️ Duel⚛️ Collide
📄 Export LaTeX
arXiv PreprintNeurIPSNature MethodsPLOS ONE
📖 Export BibTeXinteract with this hypothesis
Composite40%

🧪 Overview

NOT RECOMMENDED. Contains a biochemical error that undermines the hypothesis. IREB2 binds to IRE sequences in the 5' UTR of FTH1 mRNA and REPRESSES FTH1 translation. Therefore, IREB2 deletion would INCREASE FTH1 expression—opposite of the hypothesis. FTH1 overexpression in AD microglia may represent a compensatory protective response (iron sequestration). Ferroptosis inhibitors (ferrostatin-1 analogs) failed in human trials. IREB2 is poorly druggable (requires ASO approach).

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["GSH Depletion<br/>Glutathione Synthesis Impairment"]
    B["GPX4 Inactivation<br/>Phospholipid Peroxidase Loss"]
    C["Lipid Peroxidation<br/>Polyunsaturated Fatty Acid Radical Chain"]
    D["Peroxynitrite Formation<br/>Nitric Oxide plus Superoxide Convergence"]
    E["Ferroptotic Cell Death<br/>Iron-Dependent Membrane Rupture"]
    F["NAC Supplementation<br/>GSH Precursor and Peroxynitrite Scavenger"]
    G["Ferrostatin-1<br/>Lipid Radical Termination and Ferroptosis Block"]
    A --> B
    B --> C
    D --> C
    C --> E
    F -.->|"restores"| A
    G -.->|"inhibits"| C
    style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style C fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
    style E fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
    style F fill:#1b5e20,stroke:#81c784,color:#81c784
    style G fill:#1b5e20,stroke:#81c784,color:#81c784

⚖️ Evidence

⚖️ Evidence Matrix4 supports4 contradicts
Supports
IRP2 accumulates in microglia surrounding amyloid plaques in AD brain
PMID:29163160
Supports
FTH1 overexpression in AD microglia indicates iron dysregulation and ferroptosis signature
PMID:31201966
Supports
IREB2 deletion in mice reduces brain iron and improves behavioral outcomes
PMID:25416956
Supports
TREM2 deficiency exacerbates iron accumulation in microglia
PMID:29900273
Contradicts
IREB2 binds 5' UTR IRE sequences and REPRESSES FTH1 translation—IREB2 deletion would INCREASE FTH1
PMID:Iron metabolism biochemistry
Contradicts
FTH1 overexpression may represent compensatory iron sequestration—reducing FTH1 could paradoxically increase oxidative stress
PMID:31201966
Contradicts
Ferrostatin-1 analogs failed in human neurodegenerative disease trials
PMID:32877692
Contradicts
IREB2 knockout benefit may be due to neuronal iron deficiency, not microglial effects
PMID:25416956
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — IRP2-IRON

No curated PDB or AlphaFold mapping for IRP2-IRON yet. Search RCSB →

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for IRP2-Iron →

No DepMap CRISPR Chronos data found for IRP2-Iron.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Rising
7d Momentum
▲ 1.0%
Volatility
Low
0.0071
Events (7d)
3
Price History
▲19.9%

💾 Resource Usage

LLM Tokens
32,048
$0.0961
Total Cost
$0.0961

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF ferrostatin-1 analog (MAG-FIN-1) is administered at 10 mg/kg/day via osmotic minipump to 5xFAD mice for 12 weeks THEN lipid peroxidation markers (4-HNE adducts) in prefrontal cortex will decrease bReduced lipid peroxidation indicating decreased ferroptotic vulnerability in Alzheimer's model mice receiving ferroptosis inhibitor treatment— no observation —pending0.60
IF IREB2 is genetically deleted in 5xFAD mice (APP/PS1 double transgenic model of Alzheimer's disease) THEN FTH1 protein levels in cortical microglia will increase by >50% within 8 weeks compared to wIncreased FTH1 expression (iron sequestration) in microglia following IREB2 deletion, confirming the compensatory protective response hypothesis rather than fer— no observation —pending0.55
🔮 Falsifiable Predictions (2)
pendingconf 60%
IF ferrostatin-1 analog (MAG-FIN-1) is administered at 10 mg/kg/day via osmotic minipump to 5xFAD mice for 12 weeks THEN lipid peroxidation markers (4-HNE adducts) in prefrontal cortex will decrease by >40% compared to vehicle-treated 5xFAD mice, as measured by ELISA.
Predicted outcome: Reduced lipid peroxidation indicating decreased ferroptotic vulnerability in Alzheimer's model mice receiving ferroptosis inhibitor treatment
Falsification: 4-HNE levels show no significant difference (<20% change) between treatment and vehicle groups, indicating ferroptosis inhibitors lack efficacy in this model and supporting clinical trial failures
pendingconf 55%
IF IREB2 is genetically deleted in 5xFAD mice (APP/PS1 double transgenic model of Alzheimer's disease) THEN FTH1 protein levels in cortical microglia will increase by >50% within 8 weeks compared to wild-type littermates, as validated by Western blot and immunohistochemistry.
Predicted outcome: Increased FTH1 expression (iron sequestration) in microglia following IREB2 deletion, confirming the compensatory protective response hypothesis rathe
Falsification: FTH1 protein levels do not change significantly (<20% change) or decrease after IREB2 deletion, indicating the hypothesis incorrectly predicts FTH1 regulation
View on SciDEX ↗